The short version
- Signaling and practice are different things. A sticker on the door is not a clinical decision.
- The intake form is a clinical instrument. What it asks determines what a provider knows before the consultation starts.
- The most common failure is assuming a universal aesthetic goal, then treating toward it.
- A practice that cannot safely treat your skin type is not affirming, whatever else it says.
- Affirming does not mean agreeing. Part of the job is being willing to say no.
Nearly half of respondents to the 2022 U.S. Transgender Survey, which collected 92,329 responses, reported at least one negative experience with a health care provider related to being transgender. Around a quarter did not see a doctor when they needed to in the previous year because they expected to be treated badly.1
Those numbers describe an outcome, not a cause. The causes are ordinary and mostly procedural. Someone read the wrong name off a screen. The form had one box. Nobody asked what the goal was. The device in the room could not treat the patient in it.
All of which is fixable, and none of it is fixed by a sticker.
It starts with the form
The intake form decides what a provider knows before anyone speaks, and most forms are built to satisfy a billing system rather than to inform care.
A form that works asks gender identity and sex assigned at birth as two separate questions rather than one. It has a field for the name a patient actually uses, and that field is the one the schedule and the front desk read from. It asks about hormone therapy as a medication, because it is one, and it changes sebum, hair and healing in ways that affect what should be booked.
None of that is a courtesy. It is history taking. The difference between a practice that has this and one that does not shows up on the first visit, when a patient has to correct someone or decide not to bother.
The consultation asks about the goal, not the procedure
This is where most of the real difference lives, and it is a clinical point rather than a cultural one.
Aesthetic medicine has default targets that are assumed rather than stated. A published review of aesthetic care for lesbian, gay and bisexual patients makes the problem concrete: a gay man requesting lip augmentation may be seeking a softer, more feminine result, or may be seeking the opposite. Treating him toward a generic ideal produces a technically competent outcome that is wrong for the person.2
The fix is unremarkable. Ask what someone wants to look like before discussing what to inject. Ask whether the goal relates to how they want to be read by other people. Then choose the structure and the technique to match, because masculinizing and feminizing a face involve different anatomy and different endpoints, not different amounts of the same thing.
The same review notes that men generally require meaningfully higher neurotoxin doses than women for comparable effect, driven by muscle mass.2 Dosing off a female-derived default and calling the result a poor response is a technique problem being described as a patient problem.
The device has to be able to treat you
A practice can be entirely welcoming and still be the wrong place, because welcome is not a wavelength.
Hair removal is the clearest example, since it is one of the most requested treatments in gender-affirming care. Published guidance holds that only the 1064 nm Nd:YAG is considered appropriate for Fitzpatrick types V and VI.3 A practice running a device that cannot safely treat darker skin is not offering the treatment to everyone who walks in, regardless of what the website says.
This is worth asking about directly before booking anything. Which device, which wavelength, and how many patients with your skin type has this provider treated. Those are reasonable questions and a good practice will answer them without getting defensive. We wrote separately about what makes a laser appropriate for deeper skin tones and about the limits of the Fitzpatrick scale itself.
Affirming does not mean agreeing
This is the part that gets left out, and leaving it out does patients no favors.
Body dysmorphic disorder is the condition aesthetic medicine is obligated to screen for, because treatment reliably fails to help it and often makes it worse. It is not rare in this setting. Gay men make up an estimated 2 to 4 percent of the population and roughly 12.5 percent of documented cases.2
Wanting cosmetic treatment is not a disorder, and the overwhelming majority of people asking for it are simply people who want to look a certain way. But screening is standard of care in aesthetics, and skipping it for a patient a provider is anxious about offending is its own form of unequal treatment.
A practice that will never tell you no is not being respectful of you. It is managing its own discomfort, and occasionally its revenue. The useful version is a provider who applies the same standard to everyone, explains the reasoning when the answer is no, and offers what would actually help instead.
Privacy is a clinical feature
Who is out, and to whom, is not the practice's information to manage casually.
Practically that means the front desk does not say things out loud that belong in a room. It means the name on a reminder text is the one the patient chose. It means a chart note records what is clinically relevant rather than what is interesting, and that a patient can ask what is written about them.
People frequently arrive having already decided how much to say. The job is to make the full answer safe to give, not to require it.
What it adds up to
Almost none of this is about identity in the abstract. It is a set of specific operational choices: what the form asks, what the consultation opens with, which device is in the room, what dose the protocol starts from, what happens when the right answer is no, and who can overhear the front desk.
Each one is small. Together they determine whether someone gets care built for them or care built for someone else and offered politely.
The reasonable test for any practice is to ask about the specifics rather than the values. Values are easy to state. The form, the wavelength and the dose are matters of fact.
Common questions
What makes an aesthetics practice actually LGBTQ+ affirming?
Specific operational choices rather than stated values. An intake form that asks gender identity and sex assigned at birth separately and records the name the patient uses, a consultation that establishes the aesthetic goal before the procedure, devices capable of safely treating every skin type including Fitzpatrick V and VI, dosing protocols that are not defaulted from one population, willingness to decline treatment when it is not indicated, and handling of privacy that does not require a patient to be out to anyone they have not chosen.
What should I ask a practice before booking?
Which device and which wavelength they use, and how many patients with your skin type the provider has treated. For hair removal in darker skin, published gender-affirming care guidance holds that only 1064 nm Nd:YAG is considered appropriate for Fitzpatrick types V and VI. Ask what the intake form collects and who reads it. A good practice answers these without becoming defensive.
Why does the intake form matter so much?
Because it determines what a provider knows before the consultation starts. A single-box gender question loses clinically relevant information, and hormone therapy is a medication that changes sebum production, hair growth and healing, all of which affect what should be booked and when. It is history taking, not administrative courtesy.
Should aesthetic treatment differ for gay, lesbian or bisexual patients?
The treatment follows the individual goal rather than the identity. The relevant failure is assuming a universal aesthetic endpoint and treating toward it. A published review gives the example of a gay man seeking lip augmentation, where the intended result may be feminizing or the opposite, and the only way to know is to ask. Masculinizing and feminizing a face involve different anatomy and different endpoints, and men generally require higher neurotoxin doses than women for comparable effect.
Is it a bad sign if a provider declines to treat me?
Not usually, and the opposite can be worse. Screening for body dysmorphic disorder is standard of care in aesthetic medicine because treatment reliably fails to help it. Wanting cosmetic treatment is not itself a disorder, but a provider who never declines anything is avoiding a conversation rather than deferring to the patient. The reasonable expectation is the same standard applied to everyone, with the reasoning explained.
References
- Advocates for Trans Equality. Health and Wellbeing: Findings from the 2022 U.S. Transgender Survey. 92,329 respondents.
- Hennessy K, Dayan S, Somenek M, Bay S, Witfill K, Fabi S. Aesthetic considerations for treating lesbian, gay, and bisexual patients: a review and our experience. Journal of Clinical and Aesthetic Dermatology. 2024;17(5):34-39.
- UCSF Gender Affirming Health Program. Hair removal guidelines.
This article is for general education and is not medical advice. It does not establish a physician-patient relationship, and it cannot account for your individual history, medications or skin. Treatment decisions should be made with a clinician who has examined you in person.